| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 |
| filingDate |
1972-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1976-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PL-88998-B1 |
| titleOfInvention |
Composition and process[au4154572a] |
| abstract |
Prostaglandin analogues of formula (I) E =CH2CH2 or trans- CH=CH-; R1 = H; (1-8C) alkyl or a cation; R2 = (1-5C) alkyl, V = -(CH2)5- or cis-CH=CH- (CH2)3 but is -(CH2)5- when E = -(CH2)2- and W = 1- pentyl (or cis-1-pent-2-enyl when E = trans-CH=CH- and V = -CH-CH-(CH2)3-), have a prolonged and more specific activity than their natural counterparts.n[FR2135270A1] |
| priorityDate |
1971-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |